Literature DB >> 14993837

Role of GM3-enriched microdomains in signal transduction regulation in T lymphocytes.

Maurizio Sorice1, Agostina Longo, Tina Garofalo, Vincenzo Mattei, Roberta Misasi, Antonio Pavan.   

Abstract

Gangliosides, sialic acid containing glycosphigolipids, are ubiquitous constituents of cell plasma membranes. Each cell type shows a peculiar ganglioside expression pattern. In human T lymphocytes monosialoganglioside GM3 represents the main ganglioside constituent of cell plasma membrane where it is concentrated in glycosphingolipid-enriched microdomains (GEM). The presence of tyrosine kinase receptors, mono- (Ras, Rap) and heterotrimeric G proteins, Src-like tyrosine kinases (lck, lyn, fyn), PKC isozymes, glycosylphosphatidylinositol (GPI)-anchored proteins and, after T cell activation, the Syk-family kinase Zap-70, prompts these portions of the plasma membrane to be considered as "glycosignaling domains." In particular, during T cell activation and/or other dynamic functions of the cell, such as apoptosis, key signaling molecules are recruited to these microdomains, where they strictly interact with GM3. The association of transducer proteins with GM3 in microdomains suggests that this ganglioside is the main marker of GEM in human lymphocytes and is a component of a cell plasma membrane multimolecular signaling complex involved in cell-cell interaction, signal transduction, and cell activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14993837     DOI: 10.1023/B:GLYC.0000018018.29488.c6

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   3.009


  73 in total

Review 1.  Glycolipid-enriched caveolae and caveolae-like domains in the nervous system.

Authors:  M Masserini; P Palestini; M Pitto
Journal:  J Neurochem       Date:  1999-07       Impact factor: 5.372

Review 2.  Membrane rafts and signaling by the multichain immune recognition receptors.

Authors:  C Langlet; A M Bernard; P Drevot; H T He
Journal:  Curr Opin Immunol       Date:  2000-06       Impact factor: 7.486

3.  Association of the CD59 and CD55 cell surface glycoproteins with other membrane molecules.

Authors:  I Stefanová; V Horejsí
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

4.  A model for ganglioside behaviour in cell membranes.

Authors:  F J Sharom; C W Grant
Journal:  Biochim Biophys Acta       Date:  1978-02-21

5.  Membrane compartmentation is required for efficient T cell activation.

Authors:  R Xavier; T Brennan; Q Li; C McCormack; B Seed
Journal:  Immunity       Date:  1998-06       Impact factor: 31.745

6.  Chemokine stimulation of lymphocyte alpha 4 integrin avidity but not of leukocyte function-associated antigen-1 avidity to endothelial ligands under shear flow requires cholesterol membrane rafts.

Authors:  Revital Shamri; Valentin Grabovsky; Sara W Feigelson; Oren Dwir; Yvette Van Kooyk; Ronen Alon
Journal:  J Biol Chem       Date:  2002-08-05       Impact factor: 5.157

7.  Gangliosides: differentiation markers for murine T helper lymphocyte subpopulations TH1 and TH2.

Authors:  F Ebel; E Schmitt; J Peter-Katalinić; B Kniep; P F Mühlradt
Journal:  Biochemistry       Date:  1992-12-08       Impact factor: 3.162

8.  Ganglioside GM1 binds to the Trk protein and regulates receptor function.

Authors:  T Mutoh; A Tokuda; T Miyadai; M Hamaguchi; N Fujiki
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells.

Authors:  Ricciarda Galandrini; Ilaria Tassi; Gianfranco Mattia; Luisa Lenti; Mario Piccoli; Luigi Frati; Angela Santoni
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

10.  Monosialoganglioside GM3 induces CD4 internalization in human peripheral blood T lymphocytes.

Authors:  M Sorice; A Pavan; R Misasi; T Sansolini; T Garofalo; L Lenti; G M Pontieri; L Frati; M R Torrisi
Journal:  Scand J Immunol       Date:  1995-02       Impact factor: 3.487

View more
  15 in total

1.  Β-hexosaminidase over-expression affects lysosomal glycohydrolases expression and glycosphingolipid metabolism in mammalian cells.

Authors:  Brunella Tancini; Alessandro Magini; Barbara Bortot; Alice Polchi; Lorena Urbanelli; Sandro Sonnino; Giovanni Maria Severini; Carla Emiliani
Journal:  Mol Cell Biochem       Date:  2011-12-07       Impact factor: 3.396

2.  A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.

Authors:  Luigi Boccuto; Kazuhiro Aoki; Heather Flanagan-Steet; Chin-Fu Chen; Xiang Fan; Frank Bartel; Marharyta Petukh; Ayla Pittman; Robert Saul; Alka Chaubey; Emil Alexov; Michael Tiemeyer; Richard Steet; Charles E Schwartz
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

3.  Gangliosides of myelosupportive stroma cells are transferred to myeloid progenitors and are required for their survival and proliferation.

Authors:  Ana L Ziulkoski; Cláudia M B Andrade; Pilar M Crespo; Elisa Sisti; Vera M T Trindade; Jose L Daniotti; Fátima C R Guma; Radovan Borojevic
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

4.  Separation of sodiated isobaric disaccharides and trisaccharides using electrospray ionization-atmospheric pressure ion mobility-time of flight mass spectrometry.

Authors:  Brian H Clowers; Prabha Dwivedi; Wes E Steiner; Herbert H Hill; Brad Bendiak
Journal:  J Am Soc Mass Spectrom       Date:  2005-05       Impact factor: 3.109

5.  Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.

Authors:  Andrew Rosa Borges; Lindsay Wieczorek; Benitra Johnson; Alan J Benesi; Bruce K Brown; Richard D Kensinger; Fred C Krebs; Brian Wigdahl; Robert Blumenthal; Anu Puri; Francine E McCutchan; Deborah L Birx; Victoria R Polonis; Cara-Lynne Schengrund
Journal:  Virology       Date:  2010-09-28       Impact factor: 3.616

Review 6.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

7.  Lowering glycosphingolipid levels in CD4+ T cells attenuates T cell receptor signaling, cytokine production, and differentiation to the Th17 lineage.

Authors:  Yunxiang Zhu; Nathan Gumlaw; Jozsef Karman; Hongmei Zhao; Jinhua Zhang; Ji-Lei Jiang; Pete Maniatis; Andrea Edling; Wei-Lien Chuang; Craig Siegel; James A Shayman; Johanne Kaplan; Canwen Jiang; Seng H Cheng
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

8.  Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.

Authors:  Adel Ersek; Ke Xu; Aristotelis Antonopoulos; Terry D Butters; Ana Espirito Santo; Youridies Vattakuzhi; Lynn M Williams; Katerina Goudevenou; Lynett Danks; Andrew Freidin; Emmanouil Spanoudakis; Simon Parry; Maria Papaioannou; Evdoxia Hatjiharissi; Aristeidis Chaidos; Dominic S Alonzi; Gabriele Twigg; Ming Hu; Raymond A Dwek; Stuart M Haslam; Irene Roberts; Anne Dell; Amin Rahemtulla; Nicole J Horwood; Anastasios Karadimitris
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

9.  Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells.

Authors:  Ivan U Kouzel; Gottfried Pohlentz; Wiebke Storck; Lena Radamm; Petra Hoffmann; Martina Bielaszewska; Andreas Bauwens; Christoph Cichon; M Alexander Schmidt; Michael Mormann; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2012-12-17       Impact factor: 5.922

10.  Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand.

Authors:  Jun-Eui Park; Dianna Y Wu; Maria Prendes; Sharon X Lu; Govind Ragupathi; Nicolas Schrantz; Paul B Chapman
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.